Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
EUR | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,360 | 1,391 | 1,573 | 1,596 | 1,585 | 1,314 | 1,714 | 1,351 | 1,174 | 1,290 | | 1,290 |
% Growth | NA | 2.3% | 13.0% | 1.5% | -0.6% | -17.1% | 30.5% | -21.2% | -13.1% | 9.9% | | |
| | | | | | | | | | | | |
Cost of Revenue | (734) | (724) | (839) | (866) | (1,014) | (907) | (1,161) | (1,048) | (933) | (1,056) | | (1,056) |
Gross Profit | 626 | 667 | 734 | 730 | 572 | 407 | 554 | 303 | 241 | 234 | | 234 |
% Revenue | 46.1% | 47.9% | 46.7% | 45.8% | 36.1% | 30.9% | 32.3% | 22.4% | 20.5% | 18.1% | | 18.1% |
| | | | | | | | | | | | |
Research and Development | (19) | (20) | (22) | (21) | (23) | (23) | (32) | (30) | (24) | (25) | | (25) |
Selling and Marketing | (256) | (268) | (293) | (286) | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (35) | (46) | (53) | (46) | (250) | (244) | (271) | (242) | (214) | (234) | | (234) |
Other Inc / (Exp) | (34) | (30) | (30) | (13) | 43 | (26) | 14 | (13) | 24 | 21 | | 21 |
Total Operating Exp | (344) | (364) | (398) | (367) | (230) | (294) | (289) | (284) | (215) | (237) | | (237) |
| | | | | | | | | | | | |
Operating Income | 282 | 303 | 336 | 364 | 342 | 113 | 264 | 18 | 26 | (3) | | (3) |
% Revenue | 20.7% | 21.8% | 21.4% | 22.8% | 21.6% | 8.6% | 15.4% | 1.3% | 2.2% | -0.3% | | -0.3% |
| | | | | | | | | | | | |
Interest Expense | (8) | (5) | (4) | (2) | (5) | (7) | (6) | (7) | (12) | (28) | | (28) |
Pre-tax Income | 274 | 299 | 332 | 362 | 337 | 106 | 258 | 11 | 14 | (32) | | (32) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (191) | (338) | 0 | | 0 |
Provision for Taxes | (34) | (47) | (111) | (67) | 63 | (20) | (52) | 4 | (2) | 9 | | 9 |
Net Income to Company | 241 | 252 | 221 | 295 | 400 | 86 | 206 | (176) | (326) | (23) | | (23) |
% Margin | 17.7% | 18.1% | 14.1% | 18.5% | 25.2% | 6.5% | 12.0% | -13.0% | -27.7% | -1.8% | | -1.8% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 241 | 252 | 221 | 295 | 400 | 86 | 206 | (176) | (326) | (23) | | (23) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 191 | 338 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 241 | 252 | 221 | 295 | 400 | 86 | 206 | 15 | 13 | (23) | | (23) |
% Margin | 17.7% | 18.1% | 14.1% | 18.5% | 25.2% | 6.5% | 12.0% | 1.1% | 1.1% | -1.8% | | -1.8% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 1.80 | 1.87 | 1.62 | 2.15 | 2.89 | 0.62 | 1.49 | 0.11 | 0.09 | (0.17) | | (0.17) |
Diluted EPS (Continuing Ops) | 1.80 | 1.86 | 1.61 | 2.14 | 2.89 | 0.62 | 1.49 | 0.11 | 0.09 | (0.17) | | (0.17) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 133.63 | 134.86 | 136.25 | 137.26 | 138.17 | 138.46 | 138.22 | 138.25 | 137.98 | 137.87 | | 137.87 |
WA Diluted Shares Out. | 133.74 | 135.56 | 137.28 | 138.14 | 138.38 | 138.46 | 138.22 | 138.25 | 137.98 | 137.87 | | 137.87 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 274 | 299 | 332 | 362 | 337 | 106 | 258 | 11 | 14 | (32) | | (32) |
Addback: Net Interest Expense | 8 | 5 | 4 | 2 | 5 | 7 | 6 | 7 | 12 | 28 | | 28 |
Addback: Other Non Operating Expenses, Total | 11 | 7 | 11 | 9 | (25) | 7 | 4 | 39 | 6 | 5 | | 5 |
Addback: Depreciation & Amortization | 100 | 97 | 97 | 92 | 94 | 102 | 103 | 114 | 74 | 79 | | 79 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (1) | (1) | (1) | (0) | (2) | (1) | (1) | (1) | (0) | (1) | | (1) |
Addback: Asset Writedown | 0 | 4 | 0 | 2 | 0 | 24 | 17 | 3 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 395 | 410 | 463 | 466 | 408 | 245 | 387 | 172 | 105 | 80 | | 80 |
% Margin | 29.0% | 29.5% | 29.4% | 29.2% | 25.7% | 18.7% | 22.6% | 12.8% | 9.0% | 6.2% | | 6.2% |
| | | | | | | | | | | | |
Adjusted EBIT | 295 | 313 | 366 | 374 | 314 | 144 | 284 | 59 | 32 | 1 | | 1 |
% Margin | 21.7% | 22.5% | 23.2% | 23.4% | 19.8% | 10.9% | 16.6% | 4.4% | 2.7% | 0.1% | | 0.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 241 | 252 | 221 | 295 | 400 | 86 | 206 | (176) | (326) | (23) | | (23) |
Addback: Unusual Items | 1 | 3 | 18 | 2 | (2) | 24 | 16 | 2 | (0) | (1) | | (1) |
Less: Tax Benefit of Unusual Items (26%) | (0) | (1) | (5) | (0) | 1 | (6) | (4) | (1) | 0 | 0 | | 0 |
Adjusted Net Income | 242 | 254 | 235 | 296 | 398 | 103 | 218 | (174) | (326) | (23) | | (23) |
% Margin | 17.8% | 18.3% | 14.9% | 18.6% | 25.1% | 7.9% | 12.7% | -12.9% | -27.7% | -1.8% | | -1.8% |